Radioimmunotherapy for Indolent B-Cell Non-Hodgkin Lymphoma in Relapsed, Refractory and Transformed Disease

Author： Visser Otto J.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.20, Iss.4, 2006-01, pp. : 201-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radioimmunotherapy: Potential as a Therapeutic Strategy in Non-Hodgkin's Lymphoma

By Wun T.   Kwon D.S.   Tuscano J.M.  

BioDrugs, Vol. 15, Iss. 3, 2001-03 ,pp. : 151-162

Adis International

Access to resources Recommend Favorite

The Role of Radioimmunotherapy with Yttrium-90 Ibritumomab Tiuxetan in the Treatment of Non-Hodgkin Lymphoma

By Cheson Bruce D.  

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 309-322

Adis International

Access to resources Recommend Favorite

Temsirolimus in Relapsed and/or Refractory Mantle Cell Lymphoma†: Profile Report

By Hoy Sheridan M.   McKeage Kate  

BioDrugs, Vol. 25, Iss. 3, 2011-06 ,pp. : 193-195

Adis International

Access to resources Recommend Favorite

Toward Personalized Immunotherapy for Non-Hodgkin Lymphoma: Targeting the Idiotypic Immunoglobulin

By Armstrong Anne C.   Cheadle Eleanor J.   Hawkins Robert E.  

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 289-297

Adis International

Access to resources Recommend Favorite

Spotlight on Rituximab in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

By Cvetković Risto S.   Perry Caroline M.  

BioDrugs, Vol. 20, Iss. 4, 2006-01 ,pp. : 253-257

Adis International

Access to resources Recommend Favorite